drugset / Trial / NCT01665196

18F-FDG PET/CT for IgG4-Related Disease

NCT01665196

Phase 0 Unknown 100 enrolled Peking Union Medical College Hospital
NaSingle-groupOpen-labelDiagnostic

Summary

This is an open-label study to investigate the diagnostic performance of 18F-FDG PET/CT (positron emission tomography/computed tomography) in evaluation of patients with IgG4-related disease. A single dose of 18F-FDG will be intravenously injected into patients with IgG4-related disease before and after treatment.

Timeline

Start
2012-09
Primary completion
2017-12
Completion
2017-12

Drugs

EvaluationDrugModalityDoseRoute
Subject 18F-FDG Diagnostic / imaging agent Intravenous

Indications